Gabelli Small Cap Growth I (GACIX)

Nasdaq • Currently down 0.39 (-0.75%) in today's trading session

2 members of Congress have disclosed 2 trades in Gabelli Small Cap Growth I (GACIX) via STOCK Act filings. The most recent disclosure was a sale by Brian Babin on 19 February 2025. The most active traders have been Brian Babin (1) and Jim Costa (1). Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Gabelli Small Cap Growth I is currently trading at $51.27, positioned at 60% of its 52-week range ($44.29 – $55.98).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$51.27
24h Change
-0.39 (-0.75%)
52 Week Range
$44.29–$55.98
View on NASDAQ

Gabelli Small Cap Growth I Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for GACIX

Select to highlight on chart
2 transactions
Compliance: 0%
Brian Babin19 Feb 202512 May 2026SaleStock$1,001 - $15,000N/A
Jim Costa11 Aug 201516 May 2016SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.74B

Volume

0

Beta

1.02

P/E Ratio

-

Fundamentals

EPS

-

Div. Yield

3.89%

Open

$51.66

Day Range

$51.27 – $51.66

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2008-01-11

This fund commits at least 80% of its net assets to the stock of companies identified as small-capitalization at the time of purchase. Its principal strategy is to invest in common shares of businesses that the Advisor expects to demonstrate accelera...

No earnings data available for this stock.

Dividends

Dividend History

29 Oct 2025
Amount $1.9927
29 Oct 2024
Amount $3.1330
17 Oct 2023
Amount $3.7924
28 Nov 2022
Amount $3.8845
26 Nov 2021
Amount $6.5202
20 Nov 2020
Amount $9.5600
19 Nov 2019
Amount $10.1800
28 Nov 2018
Amount $2.3700
28 Nov 2017
Amount $3.1200
28 Nov 2016
Amount $2.0550
24 Nov 2015
Amount $1.7220
25 Nov 2014
Amount $0.9190
26 Nov 2013
Amount $1.4190
27 Dec 2012
Amount $0.1830
28 Nov 2012
Amount $1.0910
28 Nov 2011
Amount $0.7540
28 Sept 2009
Amount $0.0210
26 Nov 2008
Amount $1.4320

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about GACIX

Which members of Congress have traded GACIX?
2 members of Congress have disclosed 2 trades in Gabelli Small Cap Growth I (GACIX) under the STOCK Act. The most active traders are Brian Babin and Jim Costa.
When was GACIX most recently disclosed by Congress?
The most recent GACIX disclosure was a sale by Brian Babin on 19 February 2025.
What is the total disclosed congressional trading volume for GACIX?
Members of Congress have disclosed approximately $16K in GACIX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in GACIX?
This GACIX page updates as soon as new STOCK Act disclosures are filed for Gabelli Small Cap Growth I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.